StockData
Arrowhead Pharmaceuticals, Inc. logo

Arrowhead Pharmaceuticals, Inc. (ARWR) stock

ARWRNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Nov 12, 2026Score 5/3035% above fair value
$43.11+0.12 (+0.28%)

Close on Nov 18, 2026Market cap $6.09BP/E –Yield –

Arrowhead Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Arrowhead Pharmaceuticals's market cap was $6.97B on Nov 11, 2026, against $7.15B a year earlier. Over the last 5 years it ranged from $1.60B to $11.90B, with a median of $3.68B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$6.97B-22.7%
2025Dec 31, 2025$9.01B+285.3%
2024Dec 31, 2024$2.34B-28.8%
2023Dec 29, 2023$3.28B-23.6%
2022Dec 30, 2022$4.30B-37.9%
2021Dec 31, 2021$6.92B-11.9%
2020Dec 31, 2020$7.86B+29.7%
2019Dec 31, 2019$6.06B+451.1%
2018Dec 31, 2018$1.10B+299.4%
2017Dec 29, 2017$275.21M+154.6%
2016Dec 30, 2016$108.11M-70.5%
2015Dec 31, 2015$366.20M-9.2%
2014Dec 31, 2014$403.37M+14.4%
2013Dec 31, 2013$352.51M+1113.1%
2012Dec 31, 2012$29.06M-19.8%
2011Dec 30, 2011$36.21M-43.6%
2010Dec 31, 2010$64.19M–

More Arrowhead Pharmaceuticals figures

See a number that looks wrong?